Laurel Wealth Advisors (California)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AWA
Laurel Wealth Advisors (California)'s AMGN Position: Q4 2022 in Review
Laurel Wealth Advisors (California) increased its Amgen (AMGN) stake by 6% in Q4 2022, buying an estimated $91.4K and bringing the position to 5,995 shares worth $1.57M. The position accounts for 0.16% of the portfolio, ranked #147.
Laurel Wealth Advisors (California) first reported a position in AMGN in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.59M in Q4 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- Laurel Wealth Advisors (California) held 5,995 shares of Amgen worth $1.57M as of Q4 2022.
- Laurel Wealth Advisors (California) bought 341 Amgen shares in Q4 2022, an estimated $91.4K.
- Amgen made up 0.16% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #147 holding.
- Laurel Wealth Advisors (California) first reported a position in Amgen in Q4 2015 and has held it in 29 quarters since.
- Laurel Wealth Advisors (California)'s Amgen position peaked at $1.59M in Q4 2021.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.